Masnikosa R, Cvetkovic Z, Piric D
Int J Mol Sci. 2024; 25(21).
PMID: 39518937
PMC: 11545713.
DOI: 10.3390/ijms252111384.
Negara I, Tomuleasa C, Buruiana S, Efremov D
Cancers (Basel). 2024; 16(12).
PMID: 38927876
PMC: 11201917.
DOI: 10.3390/cancers16122170.
Yonezawa H, Narita Y, Nagane M, Mishima K, Terui Y, Arakawa Y
Neurooncol Adv. 2024; 6(1):vdae037.
PMID: 38690230
PMC: 11059299.
DOI: 10.1093/noajnl/vdae037.
Abrisqueta P
J Clin Med. 2024; 13(7).
PMID: 38610693
PMC: 11012802.
DOI: 10.3390/jcm13071929.
Cerchietti L
Blood. 2024; 143(12):1101-1111.
PMID: 38211334
PMC: 10972714.
DOI: 10.1182/blood.2023021002.
Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials.
Atallah-Yunes S, Khurana A, Maurer M
Leuk Lymphoma. 2024; 65(4):430-439.
PMID: 38180317
PMC: 10932918.
DOI: 10.1080/10428194.2023.2298705.
Molecular complexity of diffuse large B-cell lymphoma: a molecular perspective and therapeutic implications.
Almasmoum H
J Appl Genet. 2023; 65(1):57-72.
PMID: 38001281
DOI: 10.1007/s13353-023-00804-5.
Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts.
Kurz K, Ott M, Kalmbach S, Steinlein S, Kalla C, Horn H
Cancers (Basel). 2023; 15(8).
PMID: 37190213
PMC: 10137297.
DOI: 10.3390/cancers15082285.
Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling.
Rizzello C, Cancila V, Sangaletti S, Botti L, Ratti C, Milani M
Mol Cancer. 2022; 21(1):215.
PMID: 36503430
PMC: 9743519.
DOI: 10.1186/s12943-022-01687-6.
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Alaggio R, Amador C, Anagnostopoulos I, Attygalle A, de Oliveira Araujo I, Berti E
Leukemia. 2022; 36(7):1720-1748.
PMID: 35732829
PMC: 9214472.
DOI: 10.1038/s41375-022-01620-2.
Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment.
Danilov A, Magagnoli M, Matasar M
Oncologist. 2022; 27(1):57-66.
PMID: 35305092
PMC: 8842307.
DOI: 10.1093/oncolo/oyab004.
Bruton's tyrosine kinase inhibitors in primary central nervous system lymphoma-evaluation of anti-tumor efficacy and brain distribution.
Yu H, Kong H, Li C, Dong X, Wu Y, Zhuang Y
Transl Cancer Res. 2022; 10(5):1975-1983.
PMID: 35116520
PMC: 8798964.
DOI: 10.21037/tcr-21-50.
Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma.
Stirm K, Leary P, Bertram K, Gonzalo Nunez N, Wust D, Boudesco C
Oncoimmunology. 2021; 10(1):2003533.
PMID: 34858727
PMC: 8632300.
DOI: 10.1080/2162402X.2021.2003533.
Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin's lymphoma.
Bastos-Oreiro M, Suarez-Gonzalez J, Andres-Zayas C, Carrion N, Moreno S, Carbonell D
Sci Rep. 2021; 11(1):22815.
PMID: 34819573
PMC: 8613247.
DOI: 10.1038/s41598-021-02362-4.
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma.
Lee K, Koh J, Jeon Y, Kwon H, Lee J, Paik J
J Pathol Transl Med. 2021; 56(1):32-39.
PMID: 34775731
PMC: 8743803.
DOI: 10.4132/jptm.2021.10.05.
Primary central nervous system lymphoma.
Schaff L, Grommes C
Blood. 2021; 140(9):971-979.
PMID: 34699590
PMC: 9437714.
DOI: 10.1182/blood.2020008377.
Expression of N-methyladenosine (mA) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL).
Xie Z, Li M, Hong H, Xu Q, He Z, Peng Z
Bioengineered. 2021; 12(1):6115-6133.
PMID: 34482808
PMC: 8806613.
DOI: 10.1080/21655979.2021.1972644.
Antitumor efficacy of XPO1 inhibitor Selinexor in KRAS-mutant lung adenocarcinoma patient-derived xenografts.
Rosen J, Weiss J, Pham N, Li Q, Martins-Filho S, Wang Y
Transl Oncol. 2021; 14(10):101179.
PMID: 34284202
PMC: 8313753.
DOI: 10.1016/j.tranon.2021.101179.
An Overview on Diffuse Large B-Cell Lymphoma Models: Towards a Functional Genomics Approach.
Yanguas-Casas N, Pedrosa L, Fernandez-Miranda I, Sanchez-Beato M
Cancers (Basel). 2021; 13(12).
PMID: 34207773
PMC: 8226720.
DOI: 10.3390/cancers13122893.
Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).
Liu Y, Yao Q, Zhang F
Int J Oncol. 2021; 58(3):371-387.
PMID: 33650642
PMC: 7864151.
DOI: 10.3892/ijo.2021.5180.